首页> 外文学位 >Propafenone pharmacokinetics: GLC-ECD analysis; metabolic induction by phenobarbital in nonsmoking and smoking healthy volunteers; protein binding; pharmacodynamics in patients

【24h】

Propafenone pharmacokinetics: GLC-ECD analysis; metabolic induction by phenobarbital in nonsmoking and smoking healthy volunteers; protein binding; pharmacodynamics in patients

机译：普罗帕酮药代动力学：GLC-ECD分析；非吸烟和吸烟健康志愿者的苯巴比妥诱导代谢；蛋白质结合；患者的药效学

获取原文

获取原文并翻译 | 示例

页面导航

著录项
相似文献
相关主题

著录项

作者
Chan, Grace Lap-Yu;
展开▼
作者单位

The University of British Columbia (Canada);

展开▼
授予单位 The University of British Columbia (Canada);
学科
学位 Ph.D.
年度 1989
页码 1 p.
总页数 1
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-17 11:58:24

相似文献

外文文献
中文文献
专利

1. Safety, pharmacokinetics and pharmacodynamics of recombinant human tumour necrosis factor-binding protein-1 (Onercept) injected by intravenous, intramuscular and subcutaneous routes into healthy volunteers. [J] . Trinchard-Lugan I, Ho-Nguyen Q, Bilham WM, European cytokine network . 2001,第3期

机译：通过静脉内，肌肉内和皮下途径向健康志愿者体内注射重组人肿瘤坏死因子结合蛋白-1（Onercept）的安全性，药代动力学和药效学。
2. Pharmacokinetics, pharmacodynamics, safety and tolerability of APG101, a CD95-Fc fusion protein, in healthy volunteers and two glioma patients [J] . TuettenbergJ., SeizM., DebatinK.-M., International immunopharmacology . 2012,第1期

机译：APG101，一种CD95-Fc融合蛋白，在健康志愿者和两名神经胶质瘤患者中的药代动力学，药效学，安全性和耐受性
3. Pharmacokinetic and pharmacodynamic study of LFA3Ig fusion protein in healthy volunteers and patients with psoriasis [J] . Xian-ping LI, Bo ZHOU, Hao WANG, 中国药理学报：英文版 . 2008,第009期
4. Safety, tolerability, pharmacodynamics and pharmacokinetics following single subcutaneous dosesof a teverelix depot formulation in healthy male volunteers [C] . C. MacLean, F. Larsen, R. Piechatzek, Annual meeting exposition of the Controlled Release Society . 2005

机译：在健康男性志愿者中单次皮下注射Teverelix储库制剂后的安全性，耐受性，药效动力学和药代动力学
5. Evaluation of the pharmacokinetic-pharmacodynamic relationship, metabolism and plasma protein binding of the novel antitumor agent, 2-methoxyestradiol (2ME2), following oral administration in patients with solid tumors. [D] . Lakhani, Nehal Jagdish. 2005

机译：实体瘤患者口服后评估新型抗肿瘤药2-甲氧基雌二醇（2ME2）的药代动力学与药效关系，代谢和血浆蛋白结合。
6. Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lipoprotein Cholesterol Lowering: Support for a Biologics License Application Submission: Part II [O] . Xavier Nicolas, Nassim Djebli, Clémence Rauch, -1

机译：使用间接应答模型预测低密度脂蛋白胆固醇降低的健康志愿者或高胆固醇血症受试者中Alirocumab的群体药代动力学/药效学分析：支持生物制品许可申请提交：第二部分
7. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers [O] . Monteith David, Collins Emily C, Vandermeulen Corinne, 2017

机译：CGRP结合单克隆抗体LY2951742（Galcanezumab）在健康志愿者中的安全性，耐受性，药代动力学和药效动力学

Propafenone pharmacokinetics: GLC-ECD analysis; metabolic induction by phenobarbital in nonsmoking and smoking healthy volunteers; protein binding; pharmacodynamics in patients

著录项

相似文献

相关主题

期刊订阅